A novel ICP-MS strategy identifies arsenite as an inhibitor of selenocysteine-tRNASec charging
The Journal of Toxicological Sciences · 2026 · 51 (6) · 331-338
DOI: 10.2131/jts.51.331 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2026. Verfasst von Hayato Takashima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University. Hauptthemen laut MEDLINE: Arsenites, Selenocysteine, RNA, Transfer, Amino Acid-Specific, Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University.
- Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellow, Graduate School of Pharmaceutical Sciences, Tohoku University.
- Laboratory of Oncology, Graduate School of Pharmaceutical Sciences, Tohoku University.
- Faculty of Pharmaceutical Sciences, Tokushima Bunri University.
Zitieren
APA
Takashima, H., Makino, R., Taguchi, H., Takenaka, Y., Akiyama, Y., Tomikoka, Y., Sumi, D., Toyama, T., & Saito, Y. (2026). A novel ICP-MS strategy identifies arsenite as an inhibitor of selenocysteine-tRNASec charging. The Journal of Toxicological Sciences, 51(6), 331-338. https://doi.org/10.2131/jts.51.331
Vancouver
Takashima H, Makino R, Taguchi H, Takenaka Y, Akiyama Y, Tomikoka Y, et al. A novel ICP-MS strategy identifies arsenite as an inhibitor of selenocysteine-tRNASec charging. The Journal of Toxicological Sciences. 2026;51(6):331-338. doi:10.2131/jts.51.331
BibTeX
@article{Takashima2026,
author = {Takashima, Hayato and Makino, Reiko and Taguchi, Hiroki and Takenaka, Yoshika and Akiyama, Yasutoshi and Tomikoka, Yoshihisa and Sumi, Daigo and Toyama, Takashi and Saito, Yoshiro},
title = {A novel ICP-MS strategy identifies arsenite as an inhibitor of selenocysteine-tRNASec charging},
journal = {The Journal of Toxicological Sciences},
year = {2026},
volume = {51},
number = {6},
pages = {331--338},
doi = {10.2131/jts.51.331}
}
EUVIMED